The clinical guideline on External Cephalic Version (ECV) outlines the procedure's success rate, benefits, and potential risks. It recommends offering ECV at term from 37 weeks of gestation, with considerations for tocolysis and analgesia. The guideline also addresses contraindications, complications, and the importance of trained practitioners and proper facilities. It suggests anti-D immunoglobulin for D-negative women and highlights the need for timely detection of breech presentation and patient education. Further research is recommended to improve outcomes and address areas of uncertainty. Overall, the guideline emphasizes the importance of evidence-based practices and patient satisfaction in the management of breech presentation.